JC Virus Load in Progressive Multifocal Leukoencephalopathy: Analysis of the Correlation between the Viral Burden in Cerebrospinal Fluid, Patient Survival, and the Volume of Neurological Lesions
Open Access
- 15 June 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 34 (12) , 1568-1575
- https://doi.org/10.1086/340535
Abstract
JC virus (JCV) is the causative agent of progressive multifocal leukoencephalopathy (PML), a demyelinating central nervous system infection that mainly affects patients with acquired immunodeficiency syndrome. The diagnostic value of the detection of JCV DNA in cerebrospinal fluid (CSF) has been proved. A correlation between the JCV burden in CSF and the PML prognosis has been proposed. To our knowledge, the present study is the first to examine JCV burden in CSF in relation to the magnitude of neurological damage. An in-house quantitative polymerase chain reaction assay was used for measurement of the JCV burden in CSF samples from 12 patients with PML. A wide variation in JCV load (6.4 log) was found among the patient CSF samples, a finding that makes JCV load measurements worthwhile. Virus load values of µ4.68 log were associated with shorter patient survival time. No correlation was found between the virus load values and the global volume of brain tissue damaged. Our data suggest that factors other than the volume of neurological lesions influence the shedding of JCV in the CSF.Keywords
This publication has 23 references indexed in Scilit:
- JC Virus Genotypes in France: Molecular Epidemiology and Potential Significance for Progressive Multifocal LeukoencephalopathyThe Journal of Infectious Diseases, 2001
- The Effect of Potent Antiretroviral Therapy and JC Virus Load in Cerebrospinal Fluid on Clinical Outcome of Patients with AIDS‐Associated Progressive Multifocal LeukoencephalopathyThe Journal of Infectious Diseases, 2000
- Highly Active Antiretroviral Therapy and Progressive Multifocal Leukoencephalopathy: Effects on Cerebrospinal Fluid Markers of JC Virus Replication and Immune ResponseClinical Infectious Diseases, 2000
- Quantification of JC Virus DNA in the Cerebrospinal Fluid of Patients with Human Immunodeficiency Virus–Associated Progressive Multifocal Leukoencephalopathy—A Longitudinal StudyThe Journal of Infectious Diseases, 1999
- Clinical and Virological Monitoring During Treatment with Intrathecal Cytarabine in Patients with AIDS‐Associated Progressive Multifocal LeukoencephalopathyClinical Infectious Diseases, 1999
- JC virus detection in the cerebrospinal fluid of AIDS patients with progressive multifocal leucoencephalopathy and monitoring of the antiviral treatment by a PCR methodJournal of Medical Microbiology, 1997
- JC virus DNA in cerebrospinal fluid of human immunodeficiency virus—infected patients: Predictive value for progressive multifocal leukoencephalopathyAnnals of Neurology, 1995
- Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rareJournal of NeuroVirology, 1995
- Failure of cytarabine and increased JC virus-DNA burden in the cerebrospinal fluid of patients with AIDS-related progressive multifocal leucoencephalopathyAIDS, 1994
- Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluidAIDS, 1994